This report aims to provide a comprehensive presentation of the global market for Duchenne Muscular Dystrophy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Duchenne Muscular Dystrophy Drugs. This report contains market size and forecasts of Duchenne Muscular Dystrophy Drugs in global, including the following market information:
Global Duchenne Muscular Dystrophy Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Duchenne Muscular Dystrophy Drugs market was valued at US$ 1041.1 million in 2022 and is projected to reach US$ 7464.7 million by 2029, at a CAGR of 32.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Molecular-based Therapies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Duchenne Muscular Dystrophy Drugs include Biogen, Roche, Daiichi Sankyo, Pfizer, Cumberland Pharmaceuticals, Santhera Pharmaceuticals, Taiho Pharmaceutical, Teijin Pharma and Akashi Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Duchenne Muscular Dystrophy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Duchenne Muscular Dystrophy Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Duchenne Muscular Dystrophy Drugs Market Segment Percentages, by Type, 2022 (%)
- Molecular-based Therapies
- Steroid Therapy
- Other
Global Duchenne Muscular Dystrophy Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Duchenne Muscular Dystrophy Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Clinics
- Others
Global Duchenne Muscular Dystrophy Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Duchenne Muscular Dystrophy Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Duchenne Muscular Dystrophy Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Duchenne Muscular Dystrophy Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Biogen
- Roche
- Daiichi Sankyo
- Pfizer
- Cumberland Pharmaceuticals
- Santhera Pharmaceuticals
- Taiho Pharmaceutical
- Teijin Pharma
- Akashi Therapeutics
- Sarepta Therapeutics
- BioMarin
- Fibrogen Inc
- Nobelpharma Co. Ltd
- Eloxx Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Duchenne Muscular Dystrophy Drugs, market overview.
Chapter 2: Global Duchenne Muscular Dystrophy Drugs market size in revenue.
Chapter 3: Detailed analysis of Duchenne Muscular Dystrophy Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Duchenne Muscular Dystrophy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Duchenne Muscular Dystrophy Drugs Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Duchenne Muscular Dystrophy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Duchenne Muscular Dystrophy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Duchenne Muscular Dystrophy Drugs Overall Market Size
2.1 Global Duchenne Muscular Dystrophy Drugs Market Size: 2022 VS 2029
2.2 Global Duchenne Muscular Dystrophy Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Duchenne Muscular Dystrophy Drugs Players in Global Market
3.2 Top Global Duchenne Muscular Dystrophy Drugs Companies Ranked by Revenue
3.3 Global Duchenne Muscular Dystrophy Drugs Revenue by Companies
3.4 Top 3 and Top 5 Duchenne Muscular Dystrophy Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Duchenne Muscular Dystrophy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Duchenne Muscular Dystrophy Drugs Players in Global Market
3.6.1 List of Global Tier 1 Duchenne Muscular Dystrophy Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Duchenne Muscular Dystrophy Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Duchenne Muscular Dystrophy Drugs Market Size Markets, 2022 & 2029
4.1.2 Molecular-based Therapies
4.1.3 Steroid Therapy
4.1.4 Other
4.2 By Type - Global Duchenne Muscular Dystrophy Drugs Revenue & Forecasts
4.2.1 By Type - Global Duchenne Muscular Dystrophy Drugs Revenue, 2018-2023
4.2.2 By Type - Global Duchenne Muscular Dystrophy Drugs Revenue, 2024-2029
4.2.3 By Type - Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Duchenne Muscular Dystrophy Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Duchenne Muscular Dystrophy Drugs Revenue & Forecasts
5.2.1 By Application - Global Duchenne Muscular Dystrophy Drugs Revenue, 2018-2023
5.2.2 By Application - Global Duchenne Muscular Dystrophy Drugs Revenue, 2024-2029
5.2.3 By Application - Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Duchenne Muscular Dystrophy Drugs Market Size, 2022 & 2029
6.2 By Region - Global Duchenne Muscular Dystrophy Drugs Revenue & Forecasts
6.2.1 By Region - Global Duchenne Muscular Dystrophy Drugs Revenue, 2018-2023
6.2.2 By Region - Global Duchenne Muscular Dystrophy Drugs Revenue, 2024-2029
6.2.3 By Region - Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Duchenne Muscular Dystrophy Drugs Revenue, 2018-2029
6.3.2 US Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.3.3 Canada Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.3.4 Mexico Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Duchenne Muscular Dystrophy Drugs Revenue, 2018-2029
6.4.2 Germany Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.4.3 France Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.4.4 U.K. Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.4.5 Italy Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.4.6 Russia Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.4.8 Benelux Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Duchenne Muscular Dystrophy Drugs Revenue, 2018-2029
6.5.2 China Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.5.3 Japan Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.5.4 South Korea Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.5.6 India Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Duchenne Muscular Dystrophy Drugs Revenue, 2018-2029
6.6.2 Brazil Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.6.3 Argentina Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Duchenne Muscular Dystrophy Drugs Revenue, 2018-2029
6.7.2 Turkey Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.7.3 Israel Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
6.7.5 UAE Duchenne Muscular Dystrophy Drugs Market Size, 2018-2029
7 Duchenne Muscular Dystrophy Drugs Companies Profiles
7.1 Biogen
7.1.1 Biogen Company Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.1.4 Biogen Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.1.5 Biogen Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.2.4 Roche Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Daiichi Sankyo
7.3.1 Daiichi Sankyo Company Summary
7.3.2 Daiichi Sankyo Business Overview
7.3.3 Daiichi Sankyo Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.3.4 Daiichi Sankyo Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.3.5 Daiichi Sankyo Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.4.4 Pfizer Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Cumberland Pharmaceuticals
7.5.1 Cumberland Pharmaceuticals Company Summary
7.5.2 Cumberland Pharmaceuticals Business Overview
7.5.3 Cumberland Pharmaceuticals Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.5.4 Cumberland Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.5.5 Cumberland Pharmaceuticals Key News & Latest Developments
7.6 Santhera Pharmaceuticals
7.6.1 Santhera Pharmaceuticals Company Summary
7.6.2 Santhera Pharmaceuticals Business Overview
7.6.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.6.4 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.6.5 Santhera Pharmaceuticals Key News & Latest Developments
7.7 Taiho Pharmaceutical
7.7.1 Taiho Pharmaceutical Company Summary
7.7.2 Taiho Pharmaceutical Business Overview
7.7.3 Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.7.4 Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.7.5 Taiho Pharmaceutical Key News & Latest Developments
7.8 Teijin Pharma
7.8.1 Teijin Pharma Company Summary
7.8.2 Teijin Pharma Business Overview
7.8.3 Teijin Pharma Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.8.4 Teijin Pharma Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.8.5 Teijin Pharma Key News & Latest Developments
7.9 Akashi Therapeutics
7.9.1 Akashi Therapeutics Company Summary
7.9.2 Akashi Therapeutics Business Overview
7.9.3 Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.9.4 Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.9.5 Akashi Therapeutics Key News & Latest Developments
7.10 Sarepta Therapeutics
7.10.1 Sarepta Therapeutics Company Summary
7.10.2 Sarepta Therapeutics Business Overview
7.10.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.10.4 Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.10.5 Sarepta Therapeutics Key News & Latest Developments
7.11 BioMarin
7.11.1 BioMarin Company Summary
7.11.2 BioMarin Business Overview
7.11.3 BioMarin Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.11.4 BioMarin Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.11.5 BioMarin Key News & Latest Developments
7.12 Fibrogen Inc
7.12.1 Fibrogen Inc Company Summary
7.12.2 Fibrogen Inc Business Overview
7.12.3 Fibrogen Inc Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.12.4 Fibrogen Inc Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.12.5 Fibrogen Inc Key News & Latest Developments
7.13 Nobelpharma Co. Ltd
7.13.1 Nobelpharma Co. Ltd Company Summary
7.13.2 Nobelpharma Co. Ltd Business Overview
7.13.3 Nobelpharma Co. Ltd Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.13.4 Nobelpharma Co. Ltd Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.13.5 Nobelpharma Co. Ltd Key News & Latest Developments
7.14 Eloxx Pharmaceuticals
7.14.1 Eloxx Pharmaceuticals Company Summary
7.14.2 Eloxx Pharmaceuticals Business Overview
7.14.3 Eloxx Pharmaceuticals Duchenne Muscular Dystrophy Drugs Major Product Offerings
7.14.4 Eloxx Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue in Global Market (2018-2023)
7.14.5 Eloxx Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Duchenne Muscular Dystrophy Drugs Market Opportunities & Trends in Global Market
Table 2. Duchenne Muscular Dystrophy Drugs Market Drivers in Global Market
Table 3. Duchenne Muscular Dystrophy Drugs Market Restraints in Global Market
Table 4. Key Players of Duchenne Muscular Dystrophy Drugs in Global Market
Table 5. Top Duchenne Muscular Dystrophy Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Duchenne Muscular Dystrophy Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Duchenne Muscular Dystrophy Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Duchenne Muscular Dystrophy Drugs Product Type
Table 9. List of Global Tier 1 Duchenne Muscular Dystrophy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Duchenne Muscular Dystrophy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Duchenne Muscular Dystrophy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Duchenne Muscular Dystrophy Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application - Global Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Duchenne Muscular Dystrophy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Duchenne Muscular Dystrophy Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region - Global Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Biogen Company Summary
Table 31. Biogen Duchenne Muscular Dystrophy Drugs Product Offerings
Table 32. Biogen Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Biogen Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Duchenne Muscular Dystrophy Drugs Product Offerings
Table 36. Roche Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Daiichi Sankyo Company Summary
Table 39. Daiichi Sankyo Duchenne Muscular Dystrophy Drugs Product Offerings
Table 40. Daiichi Sankyo Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Daiichi Sankyo Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Duchenne Muscular Dystrophy Drugs Product Offerings
Table 44. Pfizer Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Cumberland Pharmaceuticals Company Summary
Table 47. Cumberland Pharmaceuticals Duchenne Muscular Dystrophy Drugs Product Offerings
Table 48. Cumberland Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Cumberland Pharmaceuticals Key News & Latest Developments
Table 50. Santhera Pharmaceuticals Company Summary
Table 51. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Product Offerings
Table 52. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Santhera Pharmaceuticals Key News & Latest Developments
Table 54. Taiho Pharmaceutical Company Summary
Table 55. Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Product Offerings
Table 56. Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Taiho Pharmaceutical Key News & Latest Developments
Table 58. Teijin Pharma Company Summary
Table 59. Teijin Pharma Duchenne Muscular Dystrophy Drugs Product Offerings
Table 60. Teijin Pharma Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Teijin Pharma Key News & Latest Developments
Table 62. Akashi Therapeutics Company Summary
Table 63. Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Product Offerings
Table 64. Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Akashi Therapeutics Key News & Latest Developments
Table 66. Sarepta Therapeutics Company Summary
Table 67. Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Product Offerings
Table 68. Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Sarepta Therapeutics Key News & Latest Developments
Table 70. BioMarin Company Summary
Table 71. BioMarin Duchenne Muscular Dystrophy Drugs Product Offerings
Table 72. BioMarin Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. BioMarin Key News & Latest Developments
Table 74. Fibrogen Inc Company Summary
Table 75. Fibrogen Inc Duchenne Muscular Dystrophy Drugs Product Offerings
Table 76. Fibrogen Inc Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Fibrogen Inc Key News & Latest Developments
Table 78. Nobelpharma Co. Ltd Company Summary
Table 79. Nobelpharma Co. Ltd Duchenne Muscular Dystrophy Drugs Product Offerings
Table 80. Nobelpharma Co. Ltd Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Nobelpharma Co. Ltd Key News & Latest Developments
Table 82. Eloxx Pharmaceuticals Company Summary
Table 83. Eloxx Pharmaceuticals Duchenne Muscular Dystrophy Drugs Product Offerings
Table 84. Eloxx Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Eloxx Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Duchenne Muscular Dystrophy Drugs Segment by Type in 2022
Figure 2. Duchenne Muscular Dystrophy Drugs Segment by Application in 2022
Figure 3. Global Duchenne Muscular Dystrophy Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Duchenne Muscular Dystrophy Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Duchenne Muscular Dystrophy Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Duchenne Muscular Dystrophy Drugs Revenue in 2022
Figure 8. By Type - Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2018-2029
Figure 16. US Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2018-2029
Figure 28. China Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Biogen Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Daiichi Sankyo Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Cumberland Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Teijin Pharma Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. BioMarin Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Fibrogen Inc Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Nobelpharma Co. Ltd Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Eloxx Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Global Testosterone Replacement Therapy Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 113
According to our LPI (LP Information) latest study, the global Testosterone Replacement Therapy market size was valued at US$ 1493.3 million in 2023. With growing demand in downstream market, the Testosterone Replacement Therapy is forecast to a readjusted size of US$ 1101.6 million by 2030 with a CAGR of -4.3% during review period.
The research report highlights the growth potential of the global Testosterone Replacement Therapy market. Testosterone Replacement Therapy are expected to s......
Global Finasteride Tablets Market Research Report 2024
Published: 04-Jan-2024 Price: US 2900 Onwards Pages: 96
The Finasteride Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Finasteride Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profil......
Global Erectile Dysfunction Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 108
According to our LPI (LP Information) latest study, the global Erectile Dysfunction Drugs market size was valued at US$ 4749.4 million in 2023. With growing demand in downstream market, the Erectile Dysfunction Drugs is forecast to a readjusted size of US$ 7247.8 million by 2030 with a CAGR of 6.2% during review period.
The research report highlights the growth potential of the global Erectile Dysfunction Drugs market. Erectile Dysfunction Drugs are expected to show stable growth in the ......
Global Methyltestosterone Market Research Report 2024
Published: 04-Jan-2024 Price: US 2900 Onwards Pages: 75
The Methyltestosterone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methyltestosterone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles......
Global Tamsulosin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 02-Jan-2024 Price: US 3380 Onwards Pages: 100
Market Overview of Global Tamsulosin market:
According to our latest research, the global Tamsulosin market looks promising in the next 5 years. As of 2022, the global Tamsulosin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Tamsulosin market, with a systematical de......
Global Erectile Dysfunction Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 112
Market Overview of Global Erectile Dysfunction Drug market:
According to our latest research, the global Erectile Dysfunction Drug market looks promising in the next 5 years. As of 2022, the global Erectile Dysfunction Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
Global Finasteride Tablets Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 98
Market Overview of Global Finasteride Tablets market:
According to our latest research, the global Finasteride Tablets market looks promising in the next 5 years. As of 2022, the global Finasteride Tablets market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Finasteride Ta......
Finasteride Tablets - Global Market Insights and Sales Trends 2024
Published: 19-Dec-2023 Price: US 3350 Onwards Pages: 106
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Finasteride Tablets, with both quantit......
Global Duchenne Muscular Dystrophy Drugs Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 134
Report Overview:
The Global Duchenne Muscular Dystrophy Drugs Market Size was estimated at USD 8086.70 million in 2022 and is projected to reach USD 62734.28 million by 2029, exhibiting a CAGR of 34.00% during the forecast period.
This report provides a deep insight into the global Duchenne Muscular Dystrophy Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
